AAAAAA

   
Results: 1-9 |
Results: 9
Arterial elastase activity after balloon angioplasty and effects of elafin, an elastase inhibitor
Authors: Barolet, AW Nili, N Cheema, A Robinson, R Natarajan, MK O'Blenes, S Li, J Eskandarian, MR Sparkes, J Rabinovitch, M Strauss, BH
Citation: Aw. Barolet et al., Arterial elastase activity after balloon angioplasty and effects of elafin, an elastase inhibitor, ART THROM V, 21(8), 2001, pp. 1269-1274
Bleeding risks with abciximab after full-dose thrombolysis in rescue or urgent angioplasty for acute myocardial infarction
Authors: Jong, P Cohen, EA Batchelor, W Lazzam, C Kreatsoulas, C Natarajan, MK Strauss, BH
Citation: P. Jong et al., Bleeding risks with abciximab after full-dose thrombolysis in rescue or urgent angioplasty for acute myocardial infarction, AM HEART J, 141(2), 2001, pp. 218-225
Evaluation of the role of abciximab (Reopro) as a rescue agent during percutaneous coronary interventions: In-hospital and six-month outcomes
Authors: Velianou, JL Strauss, BH Kreatsoulas, C Pericak, D Natarajan, MK
Citation: Jl. Velianou et al., Evaluation of the role of abciximab (Reopro) as a rescue agent during percutaneous coronary interventions: In-hospital and six-month outcomes, CATHET C IN, 51(2), 2000, pp. 138-144
Adventitial fibroblasts - Defining a role in vessel wall remodeling
Authors: Strauss, BH Rabinovitch, M
Citation: Bh. Strauss et M. Rabinovitch, Adventitial fibroblasts - Defining a role in vessel wall remodeling, AM J RESP C, 22(1), 2000, pp. 1-3
Homocysteine, lipoprotein(a), and restenosis after percutaneous transluminal coronary angioplasty: A prospective study
Authors: Miner, SES Hegele, RA Sparkes, J Teitel, JM Bowman, KA Connelly, PW Banijamali, H Lau, HK Chisholm, RJ Babaei, S Strauss, BH
Citation: Ses. Miner et al., Homocysteine, lipoprotein(a), and restenosis after percutaneous transluminal coronary angioplasty: A prospective study, AM HEART J, 140(2), 2000, pp. 272-278
Combined use of Orgaran and Reopro during coronary angioplasty in patientsunable to receive heparin
Authors: Cantor, WJ Leblanc, K Garvey, B Watson, KR Rasymas, A Strauss, BH
Citation: Wj. Cantor et al., Combined use of Orgaran and Reopro during coronary angioplasty in patientsunable to receive heparin, CATHET C IN, 46(3), 1999, pp. 352-355
Inhibitory mechanisms by which suramin may attenuate neointimal formation after balloon angioplasty
Authors: Gray, TJ Strauss, BH Hinek, A
Citation: Tj. Gray et al., Inhibitory mechanisms by which suramin may attenuate neointimal formation after balloon angioplasty, J CARDIO PH, 33(6), 1999, pp. 960-971
Plasma urokinase antigen and plasminogen activator inhibitor-1 antigen levels predict angiographic coronary restenosis
Authors: Strauss, BH Lau, HK Bowman, KA Sparkes, J Chisholm, RJ Garvey, MB Fenkell, LL Natarajan, MK Singh, I Teitel, JM
Citation: Bh. Strauss et al., Plasma urokinase antigen and plasminogen activator inhibitor-1 antigen levels predict angiographic coronary restenosis, CIRCULATION, 100(15), 1999, pp. 1616-1622
Failed coronary stent deployment
Authors: Cantor, WJ Lazzam, C Cohen, EA Bowman, KA Dolman, S Mackie, K Natarajan, MK Strauss, BH
Citation: Wj. Cantor et al., Failed coronary stent deployment, AM HEART J, 136(6), 1998, pp. 1088-1095
Risultati: 1-9 |